Fluticasone Furoate News
Fluticasone Furoate currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fluticasone Furoate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Asthma Indication Revinty Ellipta is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older, where use of a combination product (long-acting beta2-agonist and...
- Evidence level: L1
- Predicted indications (20):
- atopic eczema (100.0%)
- allergic asthma (100.0%)
- intrinsic asthma (100.0%)
- bronchitis (99.9%)
- asthma (99.9%)
- 2-hydroxyethyl methacrylate sensitization (99.9%)
- dermatitis, atopic (99.8%)
- contact dermatitis (99.5%)
- asthma-related traits, susceptibility to (99.4%)
- occupational dermatitis (99.3%)
- phototoxic dermatitis (99.1%)
- obstructive lung disease (98.9%)
- polyp of vocal cord (98.9%)
- polyp of middle ear (98.9%)
- fibroepithelial polyp (98.8%)
- seborrheic dermatitis (98.8%)
- neoplastic polyp (98.8%)
- atopic dermatitis (98.8%)
- polyp of vulva (98.8%)
- polyp of frontal sinus (98.8%)
Related News (1)
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.